CPHI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
China Pharma Holdings Inc (CPHI) is not a strong buy at the moment for a beginner investor with a long-term strategy. The company's financial performance shows declining profitability and weak growth trends, while technical indicators suggest no clear upward momentum. Additionally, there are no significant trading trends, news catalysts, or proprietary trading signals to support a buy decision.
The MACD is positive and expanding, indicating slight bullish momentum. RSI is neutral at 60.648, and moving averages are converging, suggesting no clear trend. Key resistance levels are at 0.671 and 0.706, while support levels are at 0.56 and 0.525. Overall, the technical indicators do not provide a strong buy signal.
NULL identified. No recent news or significant trading activity from insiders or hedge funds.
The company's financial performance is weak, with declining net income (-0.19% YoY), EPS (-66.04% YoY), and gross margin (-186.86% YoY). There is no recent congress trading data or influential figure activity to suggest confidence in the stock.
In Q4 2025, revenue increased by 8.11% YoY to $1,225,997. However, net income dropped to -$1,222,135 (-0.19% YoY), EPS fell to -0.18 (-66.04% YoY), and gross margin declined significantly to 12.3% (-186.86% YoY). The company is struggling with profitability despite slight revenue growth.
No analyst rating or price target data available.
